Catalyst Pharmaceuticals, Inc. (CPRX)
22.90
+0.10
(+0.46%)
USD |
NASDAQ |
Dec 11, 16:00
22.90
0.00 (0.00%)
After-Hours: 17:27
Catalyst Pharmaceuticals Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Collegium Pharmaceutical, Inc. | -30.87M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Amicus Therapeutics, Inc. | -1.299M |
| Rigel Pharmaceuticals, Inc. | -33.18M |
| United Therapeutics Corp. | 140.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.44M |
| Cash from Financing (Quarterly) | 4.654M |
| Free Cash Flow | 234.54M |
| Free Cash Flow Per Share (Quarterly) | 0.2552 |
| Free Cash Flow to Equity (Quarterly) | 32.54M |
| Free Cash Flow to Firm (Quarterly) | 32.44M |
| Free Cash Flow Yield | 8.06% |